Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis

World Journal of Gastroenterology

Volumn 21, Issue 12, 2015, Pages 3599-3606

  Li, Hai Lin ^a   Ji, Wen Bin ^b   Zhao, Rui ^a   Duan, Wei Dong ^b   Chen, Yong Wei ^b   Wang, Xian Qiang ^b   Yu, Qiang ^b   Luo, Ying ^b   Dong, Jia Hong ^b  

^a SHANDONG UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Disease free survival rate; Hepatocellular carcinoma; Liver transplantation; Long term survival rate; Transarterial chemoembolization

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD TURCOTTE PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATIVE BLOOD LOSS; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RETROSPECTIVE STUDY; SURGICAL PATIENT; SURVIVAL TIME; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; CHINA; GENERAL HOSPITAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LUNG TUMOR; MORTALITY; NEOADJUVANT THERAPY; PATHOLOGY; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALS, GENERAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926337903     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i12.3599     Document Type: Article

References (33)

1. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619 [PMID: 12016426 DOI: 10.1053/gast.2002.33411]
2. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7: 237-257 [PMID: 18522878]
3. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005; 11: 767-775 [PMID: 15973710 DOI: 10.1002/lt.20418]
4. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, Trevisani F, Grigioni WF, Bolondi L, Pinna AD. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78: 1780-1786 [PMID: 15614151 DOI: 10.1097/01.TP.0000145892.97114.EE]
5. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995; 23: 563-568 [PMID: 8583145 DOI: 10.1016/0168-8278(95)80063-8]
6. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, Desai NM, Chapman WC. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006; 203: 411-420 [PMID: 17000383 DOI: 10.1016/j.jamcollsurg.2006.06.016]
7. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005; 5: 795-804 [PMID: 15760404 DOI: 10.1111/j.1600-6143.2005.00750.x]
8. Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007; 13: 272-279 [PMID: 17256758 DOI: 10.1002/lt.21033]
9. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-1137 [PMID: 15841454 DOI: 10.1002/hep.20688]
10. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, MarchianòA, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909 [PMID: 15492574 DOI: 10.1097/01.sla.0000143301.56154.95]
11. Kim do Y, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 2006; 12: 6992-6997 [PMID: 17109521]
12. Nicoli N, Casaril A, Abu Hilal M, Mangiante G, Marchiori L, Ciola M, Invernizzi L, Campagnaro T, Mansueto G. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004; 188: 165-167 [PMID: 15249243 DOI: 10.1016/j.amjsurg.2003.12.061]
13. Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, Nakanishi Y, Sakamoto M. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998; 82: 1638-1642 [PMID: 9576282]
14. Koda M, Maeda Y, Matsunaga Y, Mimura K, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res 2003; 27: 163-167 [PMID: 14563432 DOI: 10.1016/S1386-6346(03)00207-9]
15. Kim SH, Choi BI, Lee JY, Kim SJ, So YH, Eun HW, Lee JM, Han JK. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation. Intervirology 2008; 51 Suppl 1: 52-60 [PMID: 18544949 DOI: 10.1159/000122598]
16. Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-234 [PMID: 15142041 DOI: 10.1111/j.1399-0012.2004.00164.x]
17. Steinmüller T, Jonas S, Neuhaus P. Review article: liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17 Suppl 2: 138-144 [PMID: 12786625 DOI: 10.1046/j.1365-2036.17.s2.2.x]
18. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002; 8: 736-748 [PMID: 12200772 DOI: 10.1053/jlts.2002.34879]
19. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, Patch D, Davidson BR, Rolles K, Burroughs AK. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81: 1532-1541 [PMID: 16770242 DOI: 10.1097/01.tp.0000209641.88912.15]
20. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563]
21. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-539 [PMID: 11923610 DOI: 10.1097/00000658-200204000-00012]
22. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998; 28: 436-442 [PMID: 9696009 DOI: 10.1002/hep.510280222]
23. Li X, Feng GS, Zheng CS, Zhuo CK, Liu X. Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study. World J Gastroenterol 2003; 9: 2445-2449 [PMID: 14606073]
24. An FQ, Matsuda M, Fujii H, Matsumoto Y. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma. J Cancer Res Clin Oncol 2000; 126: 153-160 [PMID: 10741909 DOI: 10.1007/s004320050025]
25. Li Z, Hu DY, Chu Q, Wu JH, Gao C, Zhang YQ, Huang YR. Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization. World J Gastroenterol 2004; 10: 1876-1880 [PMID: 15222027]
26. Oldhafer KJ, Chavan A, Frühauf NR, Flemming P, Schlitt HJ, Kubicka S, Nashan B, Weimann A, Raab R, Manns MP, Galanski M. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998; 29: 953-959 [PMID: 9875642 DOI: 10.1016/S0168-8278(98)80123-2]
27. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701; discussion 701-3 [PMID: 9409568 DOI: 10.1097/00000658-199712000-00006]
28. Veltri A, Grosso M, Martina MC, Ciancio A, David E, Salizzoni M, Soldano U, Galli J, Fava C. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc Intervent Radiol 1998; 21: 393-398 [PMID: 9853145 DOI: 10.1007/s002709900286]
29. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563 [PMID: 12783395 DOI: 10.1053/jlts.2003.50106]
30. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, Wiesner RH, Gores GJ. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5: 192-199 [PMID: 10226109 DOI: 10.1002/lt.500050307]
31. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995; 1: 242-248 [PMID: 9346574 DOI: 10.1002/lt.500010409]
32. Spreafico C, Marchianò A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, Milella M, Lanocita R, Mazzaferro V. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994; 192: 687-690 [PMID: 8058934 DOI: 10.1148/radiology.192.3.8058934]
33. Morino M, Miglietta C, Grosso M, De Giuli M, Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 1993; 3: 91-93 [PMID: 8389180 DOI: 10.1002/jso.2930530525]